Statin-induced myopathy: the two faces of Janus. - Wikidata - awgldk - TriplyDB

Statin-induced myopathy: the two faces of Janus.

Statin-induced myopathy: the two faces of Janus.

http://www.wikidata.org/entity/Q34554637

about

Approach to asymptomatic creatine kinase elevation Muscular effects of statins in the elderly female: a review Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia Effects of statins on skeletal muscle: a perspective for physical therapists.Atorvastatin: safety and tolerability.Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.Fluvastatin delays propagation of viral infection in isolated rat FDB myofibers but does not affect exocytic membrane trafficking.The effect of omega-3 on serum lipid profile in hemodialysis patients Simvastatin inhibits glucose metabolism and legumain activity in human myotubes.Molecular mechanisms of pharmaceutical drug binding into calsequestrin.

P2860

Q26772145-7C9E305A-2BAD-414A-94AA-5A794E8E7764 Q27023343-93E46252-3C36-4D3C-A5E2-33B981C61168 Q30875888-49020D6F-A3DE-4A34-A08B-2F99D137BB57 Q33711391-9EE06C03-B975-486F-ACD0-C3907A3BBB76 Q34173180-D08CC0F2-D80C-481B-9766-4FC5ADA1A956 Q37765562-157665E2-0662-4884-852E-30B06FF8ADCE Q38924930-BA390C84-F9B6-45C5-985E-D2515C3298F7 Q39721147-C7689BDB-69D2-4F1E-BAF3-AC25749DF5FE Q41132008-3FBC8E60-A9B4-41AC-8E34-ABE037F3D594 Q41300518-AF9247B5-C869-4EC8-A37C-81E5BF625858 Q41860525-ADE2F6C6-C012-4738-9C95-17BC670EFA9E Q42277029-21C45B38-0517-438E-B728-8B48310CAF73

P2860

Statin-induced myopathy: the two faces of Janus.

http://www.wikidata.org/entity/Q34554637

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Statin-induced myopathy: the two faces of Janus.

@ast

Statin-induced myopathy: the two faces of Janus.

@en

Statin-induced myopathy: the two faces of Janus.

@nl

type

label

Statin-induced myopathy: the two faces of Janus.

@ast

Statin-induced myopathy: the two faces of Janus.

@en

Statin-induced myopathy: the two faces of Janus.

@nl

prefLabel

Statin-induced myopathy: the two faces of Janus.

@ast

Statin-induced myopathy: the two faces of Janus.

@en

Statin-induced myopathy: the two faces of Janus.

@nl

P1433

Q34554637-4ABD8583-6DB2-478A-9B60-3259DF1D26C4

P1476

Q34554637-85A8D3C7-882C-4232-B21F-7B6CC49211CF

P2093

Q34554637-2FEF4998-AE52-407B-B21B-0367872D15E2

Q34554637-6B655931-63DE-40C7-BC3A-51D07835F97E

Q34554637-71106A69-3E96-490B-9A75-3C0A1AF570FE

P2860

Q34554637-09684477-0210-491F-B39D-340134DD5E47

Q34554637-0DD47A0E-A49B-4B0C-831B-B59A72FDE7B6

Q34554637-18FCED95-66D1-4A41-BE59-0A3490140131

Q34554637-211B2CDD-39DE-4F3E-B0EE-3B5B7556557C

Q34554637-2EC8B8E6-7235-4150-A463-D2CFC517E446

Q34554637-352B6B20-1A69-4F94-8B09-CB0EDF80909F

Q34554637-37128C16-4D1F-4205-92A9-02F3200C6954

Q34554637-37538ABE-2225-4621-A69E-117D718A728D

Q34554637-3CFA6770-A502-4E0F-9EDD-FD90AA8A1859

Q34554637-4003590B-8AEE-4598-A109-3CD9FE147EDF

P304

Q34554637-0D5DE43E-CF2B-4B86-A2E4-978FF448A919

P31

Q34554637-7C5E4872-6A9B-4997-AE62-6DC38DFE672A

P356

Q34554637-9E4D495C-1F4D-4F1D-BFCB-D38638DF67A2

P433

Q34554637-134598BB-70C4-47C4-A4C9-E543F4DB5B4F

P478

Q34554637-0E8834C8-62E2-4BC8-9F49-994D67E45DFF

P577

Q34554637-7387EC9F-A9FE-467C-B124-1164F248B6BC

P698

Q34554637-81CE9780-D475-4FF9-9C5F-DEC932080F66

P356

1074248406288758

P1433

Journal of Cardiovascular Pharmacology and Therapeutics

P1476

Statin-induced myopathy: the two faces of Janus.

@en

P2093

Frank Maldonado

http://www.w3.org/2001/XMLSchema#string

Max Liebo

http://www.w3.org/2001/XMLSchema#string

Rohit Arora

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Drug treatment of lipid disorders.

HMG-CoA reductase inhibitors and myotoxicity.

Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans.

P304

105-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1074248406288758

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16891287

http://www.w3.org/2001/XMLSchema#string